The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Malignant peripheral nerve sheath tumors: Prognostic factors and survival in a series of patients treated at a single institution
Abstract
BACKGROUND.: The authors explored the prognostic factors and clinical outcomes of patients who had malignant peripheral nerve sheath tumors (MPNST) with and without neurofibromatosis type 1 (NF‐1). METHODS.: Two hundred five patients with localized MPNST who underwent surgery at the Istituto Nazionale per lo Studio e la Cura dei Tumori (Milan, Italy) over 25 years were reviewed. Forty‐six patients had concomitant NF‐1 syndrome, and 159 patients did not. Local recurrence, distant metastases, and survival rates were studied. RESULTS.: One hundred thirty patients presented with primary disease, and 75 patients had locally recurrent tumors. The disease‐specific mortality rate was 43% at 10 years, with a continuously disease‐free survival rate of no greater than 40%. Presentation with either primary or recurrent disease, tumor size, and tumor site (trunk vs. extremity) were the strongest independent predictors of survival. Margin status and radiation therapy also played a role, mostly related to their effect on local outcome. Pathologic grade influenced distant metastases, but only a trend for survival could be observed. No significant independent differences between patients with and without NF‐1 were observed. CONCLUSIONS.: To the authors' knowledge, this was among the largest single‐institution series to date. The results confirmed that patients with MPNST share similar prognostic factors with patients who have other soft tissue sarcomas and have some of the worst clinical outcomes. The presence of NF‐1 syndrome per se did not affect survival, but patients with NF‐1 were more likely to have larger tumors. Therefore, such patients should be followed carefully to detect disease as early as possible. Cancer 2006. © 2006 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Partial residuals for the proportional hazards regression model
SCHOENFELD, D. (1982) · Biometrika · doi:10.1093/biomet/69.1.239 · Cited by 3,111
Flexible regression models with cubic splines
Durrleman, S., & Simon, R. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080504 · Cited by 2,689
A System for the Surgical Staging of Musculoskeletal Sarcoma
ENNEKING, W. F., SPANIER, S. S., & GOODMAN, M. A. (1980) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198011000-00013 · Cited by 2,500
Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases
Ducatman, B. S., Scheithauer, B. W., Piepgras, D. G., Reiman, H. M., & Ilstrup, D. M. (1986) · Cancer · doi:10.1002/1097-0142(19860515)57:10<2006::aid-cncr2820571022>3.0.co;2-6 · Cited by 1,581
Trojani, M., Contesso, G., Coindre, J. M., Rouesse, J., Bui, N. B., De Mascarel, A., Goussot, J. F., David, M., Bonichon, F., & Lagarde, C. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910330108 · Cited by 1,317
A system for the surgical staging of musculoskeletal sarcoma.
Enneking, W. F., Spanier, S. S., & Goodman, M. A. (1981) · PubMed · Cited by 1,001
Zagars, G. K., Ballo, M. T., Pisters, P. W. T., Pollock, R. E., Patel, S. R., Benjamin, R. S., & Evans, H. L. (2003) · Cancer · doi:10.1002/cncr.11365 · Cited by 681
Long-Term Follow-up of von Recklinghausen Neurofibromatosis
Sørensen, S. A., Mulvihill, J. J., & Nielsen, A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604173141603 · Cited by 617
Postoperative Nomogram for 12-Year Sarcoma-Specific Death
Kattan, M. W., Leung, D. H. Y., & Brennan, M. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.791 · Cited by 609
Stojadinovic, A., Leung, D. H. Y., Hoos, A., Jaques, D. P., Lewis, J. J., & Brennan, M. F. (2002) · Annals of Surgery · doi:10.1097/00000658-200203000-00015 · Cited by 580
Malignant peripheral nerve sheath tumor: analysis of treatment outcome
Wong, W. W., Hirose, T., Scheithauer, B. W., Schild, S. E., & Gunderson, L. L. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00223-5 · Cited by 458
Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases
Hruban, R. H., Shiu, M. H., Senie, R. T., & Woodruff, J. M. (1990) · Cancer · doi:10.1002/1097-0142(19900915)66:6<1253::aid-cncr2820660627>3.0.co;2-r · Cited by 366
D'Agostino, A. N., Soule, E. H., & Miller, R. H. (1963) · Cancer · doi:10.1002/1097-0142(196308)16:8<1015::aid-cncr2820160808>3.0.co;2-i · Cited by 365
Surgical margins, local recurrence and metastasis in soft tissue sarcomas
Trovik, C. S., Bauer, H. C. F., Alvegård, T. A., Anderson, H., Blomqvist, C., Berlin, Ö., Gustafson, P., Sæter, G., & Wallöe, A. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00287-7 · Cited by 327
Elevated Risk for MPNST in NF1 Microdeletion Patients
De Raedt, T., Brems, H., Wolkenstein, P., Vidaud, D., Pilotti, S., Perrone, F., Mautner, V., Frahm, S., Sciot, R., & Legius, E. (2003) · The American Journal of Human Genetics · doi:10.1086/374821 · Cited by 310
Self-citationGronchi, A., Casali, P. G., Mariani, L., Miceli, R., Fiore, M., Lo Vullo, S., Bertulli, R., Collini, P., Lozza, L., Olmi, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.160 · Cited by 279
Self-citationAssociation of local recurrence with subsequent survival in extremity soft tissue sarcoma.
Lewis, J. J., Leung, D., Heslin, M., Woodruff, J. M., & Brennan, M. F. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.646 · Cited by 254
Mariani, L., Miceli, R., Kattan, M. W., Brennan, M. F., Colecchia, M., Fiore, M., Casali, P. G., & Gronchi, A. (2005) · Cancer · doi:10.1002/cncr.20778 · Cited by 211
Self-citationAnalysing Survival Data from Clinical Trials and Observational Studies.
Watkins, J. F., Marubini, E., & Valsecchi, M. G. (1996) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2988484 · Cited by 148
Rb and TP53 Pathway Alterations in Sporadic and NF1-Related Malignant Peripheral Nerve Sheath Tumors
Birindelli, S., Perrone, F., Oggionni, M., Lavarino, C. E., Pasini, B., Vergani, B., Ranzani, G. N., Pierotti, M. A., & Pilotti, S. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780293 · Cited by 121
Self-citationSurvival Data for Patients with Malignant Schwannoma
Cashen, D. V., Parisien, R. C., Raskin, K. A., Hornicek, F. J., Gebhardt, M. C., & Mankin, H. J. (2004) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000131256.82455.c5 · Cited by 120
Marubini, E., & Valsecchi, M. G. (1996) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1996.tb00162.x · Cited by 107
Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): A 10-year experience
Vauthey, J., Woodruff, J. M., & Brennan, M. F. (1995) · Annals of Surgical Oncology · doi:10.1007/bf02303627 · Cited by 96
Perrone, F., Tabano, S. M., Colombo, F., Dagrada, G. P., Birindelli, S., Gronchi, A., Colecchia, M., Pierotti, M. A., & Pilotti, S. (2003) · PubMed · Cited by 81
Self-citation
Cited by
Zou, C., Smith, K. D., Liu, J., Lahat, G., Myers, S., Wang, W.-L., Zhang, W., McCutcheon, I. E., Slopis, J. M., Lazar, A. J., et al. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181a77e9a · Cited by 313
Kolberg, M., Holand, M., Agesen, T. H., Brekke, H. R., Liestol, K., Hall, K. S., Mertens, F., Picci, P., Smeland, S., & Lothe, R. A. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos287 · Cited by 270
Metadata
- Authors
- Anghileri, M., Miceli, R., Fiore, M., Mariani, L., Ferrari, A., Mussi, C., Lozza, L., Collini, P., Olmi, P., Casali, P. G., Pilotti, S., & Gronchi, A.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2006-07-31
- Volume
- 107
- Issue
- 5
- Pages
- 1065-1074
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2032220244
- Cited by
- 436
- References
- 24
- FWCI
- 8.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.